Maternal-to-fetal allopurinol transfer and xanthine oxidase suppression in the late gestation pregnant rat

Physiological Reports

Volumn 1, Issue 6, 2013, Pages 1-6

  Kane, Andrew D ^a   Camm, Emily J ^a   Richter, Hans G ^a,c   Lusby, Ciara ^a   Tijsseling, Deodata ^b   Kaandorp, Joepe J ^b   Derks, Jan B ^b   Ozanne, Susan E ^a   Giussani, Dino A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Allopurinol; Fetus; Oxypurinol; Xanthine oxidase

Indexed keywords

ALLOPURINOL; OXIPURINOL; RESORUFIN; XANTHINE OXIDASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPHYXIA; CONTROLLED STUDY; ENZYME REPRESSION; EUTHANASIA; FEMALE; FETUS HYPOXIA; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LAPAROTOMY; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; RAT;

EID: 85008884238     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.156     Document Type: Article

References (24)

1. Benders, M., A. Bos, C. Rademaker, M. Rijken, H. Torrance, F. Groenendaal, et al. 2006. Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch. Dis. Child. Fetal Neonatal Ed. 91: 163–165.
2. Berry, C. and M. Hare. 2004. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555: 589–606.
3. Boda, D., I. Németh, P. Hencz, and K. Dénes. 1984. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Dev. Pharmacol. Ther. 7: 357–367.
4. Boda, D., P. Nemeth, P. Kiss, and H. Orvos. 1999. Treatment of mothers with allopurinol to produce therapeutic blood levels in newborns. Prenat. Neonat. Med. 4: 130–134.
5. Camm, E. J., J. A. Hansell, A. D. Kane, E. A. Herrera, C. Lewis, S. Wong, et al. 2010. Partial contributions of developmental hypoxia and undernutrition to prenatal alterations in somatic growth and cardiovascular structure and function. Am. J. Obstet. Gynecol. 203: 495.
6. Chaudhari, T. and W. McGuire. 2008. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy. Cochrane Database Syst. Rev. 16: CD006817.
7. Derks, J. B., M. Oudijk, K. Rosen, A. S. Thakor, G. Visser, F. van Bel, et al. 2006. Allopurinol maintains umbilical blood flow following repeated episodes of ischaemia-reperfusion in fetal sheep during late gestation [abstract]. J. Soc. Gynecol. Invest. 13: s35.
8. Derks, J. B., M. Oudijk, H. Torrance, C. Rademaker, M. Benders, K. Rosen, et al. 2010. Allopurinol reduces oxidative stress in the ovine fetal cardiovascular system following repeated episodes of ischemia-reperfusion. Pediatr. Res. 68: 374–38
9. van Dijk, A. N., Parvizi I, M. Taverne, and J. Fink-Gremmels. 2008. Placental transfer and pharmacokinetics of allopurinol in late pregnant sows and their fetuses. J. Vet. Pharmacol. Ther. 31: 489–495.
10. Goodman, L., J. Lazo, K. Parker, L. Brunton, and A. Gilman. 2005. Goodman & Gilman’s the pharmacological basis of therapeutics. McGraw-Hill Medical, New York, NY.
11. Herrera, E. A., A. D. Kane, J. A. Hansell, A. S. Thakor, B. J. Allison, Y. Niu, et al. 2012. A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep. J. Physiol. 590: 1825–1837.
12. Kaandorp, J., M. Benders, C. Rademaker, H. Torrance, M. Oudijk, T. de Haan, et al. 2010. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study. BMC Preg. Childbirth 10: 8.
13. Kaandorp, J. J., J. B. Derks, M. A. Oudijk, H. L. Torrance, M. Harmsen, P. Nikkels, et al. 2011a. Antenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep. Reprod. Sci. 18: 364A.
14. Kaandorp, J. J., F. van Bel, S. Veen, J. B. Derks, F. Groenendaal, M. Rijken, et al. 2011b. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials. Arch. Dis. Child. Fetal Neonatal Ed. 97: F162–F166.
15. Kaandorp, J. J., F. van Bel, S. Veen, J. B. Derks, F. Groenendaal, M. Rijken, et al. 2012. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials. Arch. Dis. Child. Fetal Neonatal Ed. 97: F162–F166.
16. Kaandorp, J. J., J. B. Derks, M. A. Oudijk, H. L. Torrance, M. G. Harmsen, P. G. J. Nikkels, et al. 2013. Antenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep. Reprod. Sci. doi: 10.1177/1933719113493516 [Epub ahead of print].
17. van Kesteren, C., M. Benders, F. Groenendaal, F. van Bel, F. Ververs, and C. Rademaker. 2006. Population pharmacokinetics of allopurinol in full-term neonates with perinatal asphyxia. Ther. Drug Monit. 28: 339–344.
18. Klein, A. S., J. W. Joh, U. Rangan, D. Wang, and G. B. Bulkley. 1996. Allopurinol: discrimination of antioxidant from enzyme inhibitory activities. Free Radical Biol. Med. 21: 713–717.
19. Low, J. A. 2004. Reflections on the occurrence and significance of antepartum fetal asphyxia. Best Pract. Res. Clin. Obst. Gynaecol. 18: 375–382.
20. Masaoka, N., Y. Nakajima, Y. Hayakawa, S. Ohgame, S. Hamano, M. Nagaishi, et al. 2005. Transplacental effects of allopurinol on suppression of oxygen free radical production in chronically instrumented fetal lamb brains during intermittent umbilical cord occlusion. J. Mat.-Fetal Neon. Med. 18: 1–7.
21. Parks, D. and D. Granger. 1986. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol. Scand. 548: 87–99.
22. Peeters-Scholte, C., K. Braun, J. Koster, N. Kops, K. Blomgren, G. Buonocore, et al. 2003. Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr. Res. 54: 516–522.
23. Torrance, H. L., M. J. Benders, J. B. Derks, C. M. A. Rademaker, A. F. Bos, P. Van Den Berg, et al. 2009. Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 124: 350–357.
24. Van Bel, F., M. Shadid, R. Moison, C. Dorrepaal, J. Fontijn, L. Monteiro, et al. 1998. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 101: 185–193.